v3 Template
V

Vaxxas

Healthcare/Biotechnology ~380 employees
Founded
--
Employees (Est.)
~380
19 leaders known
Total Funding
$67.5M
Funding Rounds
3
Last Funding
2025-08-25

About Vaxxas

Vaxxas is a company focused on commercializing a novel vaccination technology called HD-MAP, which enhances the performance of existing and next-generation vaccines through a needle-free delivery system.

Products & Services

HD-MAP Technology:A needle-free vaccination platform that uses a patch with vaccine-coated microprojections applied to the skin via an applicator device to deliver vaccines efficiently to immune cells.
HD-MAP technology platform
HD-MAP applicator device

Specialties

Needle-Free Vaccination Technology Vaccine Delivery Systems HD-MAP Platform Needle-free vaccine delivery Microprojection array patches Vaccine manufacturing scale-up

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series D Equity and Debt Financing
T: -
FT: Series D Equity and Debt Financing
A: 59000000
MR: -
FA: A$90 million
FAN: 59000000
D: 2025-08-25
FD: 2025-08-25
4 investors
2 RT: Program Funding
T: -
FT: Program Funding
A: 4800000
MR: -
FA: US$4.8 million
FAN: 4800000
D: 2025-01-22
FD: 2025-01-22
1 investors
3 RT: Grant
T: -
FT: Grant
A: 3670000
MR: -
FA: US$3.67 million
FAN: 3670000
D: 2023-08-23
FD: 2023-08-23
1 investors
Series D Equity and Debt Financing Latest
2025-08-25
$59.0M
4 investors (Pro only)
Program Funding 2025-01-22
$4.8M
Grant 2023-08-23
$3.7M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

David Peacock

Chief Executive Officer

A

Angus Forster

Chief Technology Officer

S

Scott Fry

Chief Operating Officer

T

Tom Lake

Chief Business Officer

M

Melanie Farris

Chief Corporate Affairs Officer

D

Deborah Pascoe

Senior Vice President - CMC Development

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Vaxxas Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
vaxxas.com
Industries
Healthcare/Biotechnology
Company Size
~380 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro